Literature DB >> 20423763

[IL-6 and TNF-α gene expression in the rectal mucosal of patients with chronic idiopathic ulcerative colitis and controls].

G C Fonseca-Camarillo1, M A Villeda-Ramírez, F Sánchez-Muñoz, R Barreto-Zúñiga, A Domínguez-López, M Uribe-Esquivel, J K Yamamoto-Furusho.   

Abstract

BACKGROUND: It has been reported that pro-inflammatory cytokines levels like IL-6 and TNF-α can determine the degree of inflammation of ulcerative colitis (UC). AIMS: To measure the gene expression of IL-6 and TNF-á in patients with UC and controls and to correlate with histological activity. PATIENTS AND METHODS: We studied 36 patients with UC, 13 healthy controls and 11 with inflammation. After total ribonucleic acid (RNA) extraction, complementary deoxyribonucleic acid (DNA) was synthesized by polymerase chain reaction (PCR) and relative expression was determined through real-time PCR for IL-6 and TNF-á. Statistical analysis was performed using the Kruskal-Wallis test and Spearman correlation.
RESULTS: The expression of IL-6 increases in patients with active UC compared to controls (p = 0.004) as well as UC patients in remission (p = 0.014). There was no significant difference between patients with active UC and controls with inflammation. (p = 0.446). Gene expression of TNF-α was higher in biopsies from patients with UC activity compred with control subjects (p = 0.004), as well as those in remission (p = 0.001). The expression of IL-6 correlated significantly (p = 0.02) with histological activity.
CONCLUSIONS: The gene expression of IL-6 and TNF-α is increased in active UC. Interleukin 6 is better marker of bowel inflammation because its expression correlates with histological activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20423763

Source DB:  PubMed          Journal:  Rev Gastroenterol Mex        ISSN: 0375-0906


  6 in total

1.  Transcript levels of Toll-Like Receptors 5, 8 and 9 correlate with inflammatory activity in Ulcerative Colitis.

Authors:  Fausto Sánchez-Muñoz; Gabriela Fonseca-Camarillo; Marco A Villeda-Ramírez; Elizabeth Miranda-Pérez; Edgar J Mendivil; Rafael Barreto-Zúñiga; Misael Uribe; Rafael Bojalil; Aarón Domínguez-López; Jesús K Yamamoto-Furusho
Journal:  BMC Gastroenterol       Date:  2011-12-20       Impact factor: 3.067

2.  Changes in energy metabolism after induction therapy in patients with severe or moderate ulcerative colitis.

Authors:  Mai Inoue; Masaya Sasaki; Azusa Takaoka; Mika Kurihara; Hiromi Iwakawa; Shigeki Bamba; Hiromitsu Ban; Akira Andoh
Journal:  J Clin Biochem Nutr       Date:  2015-03-28       Impact factor: 3.114

3.  The Transient Receptor Potential Vanilloid 1 Is Associated with Active Inflammation in Ulcerative Colitis.

Authors:  Joel Jesús Toledo-Mauriño; Janette Furuzawa-Carballeda; Marco A Villeda-Ramírez; Gabriela Fonseca-Camarillo; Daniela Meza-Guillen; Rafael Barreto-Zúñiga; Jesús K Yamamoto-Furusho
Journal:  Mediators Inflamm       Date:  2018-07-29       Impact factor: 4.711

4.  Maggot protein ameliorates dextran sulphate sodium-induced ulcerative colitis in mice.

Authors:  Rong Wang; Lei Wang; Yongzheng Luo; Daojuan Wang; Ronghui Du; Jiancheng Du; Yong Wang
Journal:  Biosci Rep       Date:  2018-11-28       Impact factor: 3.840

5.  Protective effect of α7 nicotinic acetylcholine receptor activation on experimental colitis and its mechanism.

Authors:  Wenyuan Pu; Zhenzi Su; Junaid Wazir; Chen Zhao; Lulu Wei; Ranran Wang; Qiyi Chen; Saifang Zheng; Shaoyi Zhang; Hongwei Wang
Journal:  Mol Med       Date:  2022-09-04       Impact factor: 6.376

6.  Ixeris dentata NAKAI Reduces Clinical Score and HIF-1 Expression in Experimental Colitis in Mice.

Authors:  Dae-Seung Kim; Jang-Ho Ko; Yong-Deok Jeon; Yo-Han Han; Hyun-Ju Kim; Amrit Poudel; Hyun-Ju Jung; Sae-Kwang Ku; Su-Jin Kim; Sang-Hyun Park; Jin-Han Park; Byung-Min Choi; Sung-Joo Park; Jae-Young Um; Seung-Heon Hong
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-08       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.